Pharma & Healthcare
Biologic Response Modifiers
- Types
- Tumor Vaccines · Angiogenic Inhibitors · Tyrosine Kinase Inhibitors
- Applications
- Hospital · Clinic · Others
5 editions20 December 2025
Compare the product scope, applications and research editions relevant to your next decision.
Pharma & Healthcare
5 editions20 December 2025
Pharma & Healthcare
5 editions22 December 2025
Pharma & Healthcare
PD-1 inhibitors and PD-L1 inhibitors are a group of checkpoint inhibitors being developed for the treatment of cancer. PD-1 and PD-L1 are both proteins present on the surface of cells. Immune checkpoint inhibitors such as these are emerging as a front-line treatment for several types of cancer.
5 editions30 December 2025
Pharma & Healthcare
5 editions30 December 2025
Pharma & Healthcare
5 editions22 December 2025
Pharma & Healthcare
5 editions20 December 2025
Pharma & Healthcare
5 editions22 December 2025
Pharma & Healthcare
5 editions27 December 2025
Pharma & Healthcare
Eye drops are liquid solutions or suspensions intended for administration into the eye, applied directly to the surface of the eye usually in small amounts such as a single drop or a few drops. Eye drops usually contain saline to match the salinity of the eye. Drops containing only saline and sometimes a lubricant are often used as artificial tears to treat dry eyes or simple eye irritation such as itching or redness. Eye drops may also contain one or more medications to…
5 editions21 December 2025
Pharma & Healthcare
Oncaspar is a cancer medicine used in adults and children to treat acute lymphoblastic leukaemia (ALL), a cancer of white blood cells called lymphoblasts. Oncaspar is used in combination with other cancer medicines.
5 editions20 December 2025
Pharma & Healthcare
5 editions22 December 2025
Pharma & Healthcare
5 editions22 December 2025